Hoffman TJ - Search Results

1

Tetradentate bis-phosphine ligands (P(2)N(2) and P(2)S(2)) and their Rh(III), Ni(II) and (105)Rh complexes: X-ray crystal structures of trans-[RhCl(2)(L2)]PF(6), [Ni(L2)](PF(6))(2) and μ-O(2)SO(2)-[Ni(L5)](2)(PF(6))(2).

Cagnolini A, Ballard B, Engelbrecht HP, Rold TL, Barnes C, Cutler C, Hoffman TJ, Kannan R, Katti K, Jurisson SS. Cagnolini A, et al. Among authors: hoffman tj. Nucl Med Biol. 2011 Jan;38(1):63-76. doi: 10.1016/j.nucmedbio.2010.06.013. Epub 2010 Sep 1. Nucl Med Biol. 2011. PMID: 21220130

2

Formation of a stable 99mTc-tri-hydrazidophosphine oxide (99mTc-THP) chelate.

Corlija M, Katti KV, Volkert WA, Hoffman TJ, Higginbotham C, Holmes RA. Corlija M, et al. Among authors: hoffman tj. J Nucl Biol Med (1991). 1992 Jul-Sep;36(3):296-300. J Nucl Biol Med (1991). 1992. PMID: 1486126

3

Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination.

Giblin MF, Wang N, Hoffman TJ, Jurisson SS, Quinn TP. Giblin MF, et al. Among authors: hoffman tj. Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12814-8. doi: 10.1073/pnas.95.22.12814. Proc Natl Acad Sci U S A. 1998. PMID: 9788997 Free PMC article.

4

99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.

Karra SR, Schibli R, Gali H, Katti KV, Hoffman TJ, Higginbotham C, Sieckman GL, Volkert WA. Karra SR, et al. Among authors: hoffman tj. Bioconjug Chem. 1999 Mar-Apr;10(2):254-60. doi: 10.1021/bc980096a. Bioconjug Chem. 1999. PMID: 10077475

5

Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.

Chen J, Cheng Z, Hoffman TJ, Jurisson SS, Quinn TP. Chen J, et al. Among authors: hoffman tj. Cancer Res. 2000 Oct 15;60(20):5649-58. Cancer Res. 2000. PMID: 11059756

6

Development of an in vitro model for assessing the in vivo stability of lanthanide chelates.

Li WP, Ma DS, Higginbotham C, Hoffman T, Ketring AR, Cutler CS, Jurisson SS. Li WP, et al. Nucl Med Biol. 2001 Feb;28(2):145-54. doi: 10.1016/s0969-8051(00)00196-7. Nucl Med Biol. 2001. PMID: 11295425

7

Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.

Gali H, Hoffman TJ, Sieckman GL, Owen NK, Katti KV, Volkert WA. Gali H, et al. Among authors: hoffman tj. Bioconjug Chem. 2001 May-Jun;12(3):354-63. doi: 10.1021/bc000077c. Bioconjug Chem. 2001. PMID: 11353532

8

Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells.

Hoffman TJ, Quinn TP, Volkert WA. Hoffman TJ, et al. Nucl Med Biol. 2001 Jul;28(5):527-39. doi: 10.1016/s0969-8051(01)00209-8. Nucl Med Biol. 2001. PMID: 11516698

9

In vivo evaluation of an 111In-labeled ST-peptide analog for specific-targeting of human colon cancers.

Gali H, Sieckman GL, Hoffman TJ, Owen NK, Chin DT, Forte LR, Volkert WA. Gali H, et al. Among authors: hoffman tj. Nucl Med Biol. 2001 Nov;28(8):903-9. doi: 10.1016/s0969-8051(01)00276-1. Nucl Med Biol. 2001. PMID: 11711309

10

Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties.

Chen J, Cheng Z, Owen NK, Hoffman TJ, Miao Y, Jurisson SS, Quinn TP. Chen J, et al. Among authors: hoffman tj. J Nucl Med. 2001 Dec;42(12):1847-55. J Nucl Med. 2001. PMID: 11752084 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters